Global Oncology Academy

The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer

ReachMD Healthcare Image

As immunotherapy begins to move into the field of triple-negative breast cancer, what do we need to know?

  • Overview

    Immunotherapy is starting to make its way in breast cancer, especially triple-negative breast cancer. So how do we identify which of our patients are good candidates for this treatment? Joining Dr. Pavani Chalasani to share the most recent research on immunotherapy is Dr. Nan Chen, an Assistant Professor of Medicine at the University of Chicago. 

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free